Rocketing Chinese stocks fall to earth

Investor exuberance in soaring Chinese stocks have been checked by a one-day plunge in the stockmarket.

For most of the last three years, mainland Chinese stocks have gone nowhere. But in the past three months, they have gone beserk. The Shanghai Composite index has jumped by 40% since July and by 32% in the past six weeks.

Turnover on the stockmarket has increased fivefold to over 500 million yuan in the past few weeks. More than one million new stock-trading accounts were opened in November alone.

The boom has "reached outright mania", says Ambrose Evans-Pritchard in The Daily Telegraph. The regulator is rattled. "We hope that all investors, especially small and medium-sized investors, who are newly entering the market, will invest rationally [and] keep the risk of the equity market firmly in mind," the China Securities Regulatory Commission said last week.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

New local investors soon got a lesson in the risks of investing in equities. Early this week the index suffered its worst one-day slide for five years, an 8% drop.

Why Shanghai has rocketed

However, analysts have pointed out that the initial surge coincided with a series of articles in the state media highlighting how cheap equities were. Their timing was good: it has become increasingly clear that property is on the slide, while interest rates available on savings accounts are falling.

The articles convinced many that "the government was determined to see the market rise", says Capital Economics. "Resulting enthusiasm has to some extent now become self-reinforcing."

This helps explain why many local investors have been borrowing to finance their share purchases. Margin debt has soared to almost one trillion yuan, around 1.2% of GDP, from almost nothing three years ago.

High-margin debts increase the danger that investors hit by losses are forced to sell more stocks to cover calls for more capital from their brokers. This exacerbates corrections, as this week's nasty slide underlined.

Meanwhile, the shares that have done best so far "mainly represent the growth model that China's leaders say they want to leave behind", says Gabriel Wildau in the FT. Banks and real-estate developers have been among the top sectors. This is because investors believe "a fresh easing cycle is underway" to shore up a sharply slowing economy.

Betting on stimulus

In essence, Chinese stocks are "taking a turn on the monetary merry-go-round", says John Foley on breakingviews.com. Whether investors are right to bet on more stimulus coming soon is unclear. The government may disappoint markets by sticking to its "tough love' plans to wean the economy off excess credit", says Evans-Pritchard.

But valuations are still cheap, which suggests further turbulence is mostly priced in. The market is on a 2015 price-to-earnings ratio of ten and a cyclically adjusted p/e of 12. To invest in mainland stocks (as opposed to Hong Kong-listed ones), try the db x-trackers Harvest CSI 300 ETF (LSE: ASHR).

Andrew Van Sickle

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.